Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies’ adaptive sampling

Pharmacogenomics (PGx) studies the impact of interindividual genomic variation on drug response, allowing the opportunity to tailor the dosing regimen for each patient. Current targeted PGx testing platforms are mainly based on microarray, polymerase chain reaction, or short-read sequencing. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Deserranno, Koen, Tilleman, Laurentijn, Rubben, Kaat, Deforce, Dieter, Van Nieuwerburgh, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679755/
https://www.ncbi.nlm.nih.gov/pubmed/38026945
http://dx.doi.org/10.3389/fphar.2023.1286764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679755/
https://www.ncbi.nlm.nih.gov/pubmed/38026945
http://dx.doi.org/10.3389/fphar.2023.1286764

Ejemplares similares